MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Malignant neoplasm of left kidney, except renal pelvis (C64.2)

HealthDay 31 January at 04.49 PM

Pembrolizumab Shows Survival Benefit for Patients With Renal Cancer

For patients with clear-cell renal cell carcinoma (ccRCC), overall survival (OS) is improved for those receiving pembrolizumab versus placebo at a median follow-up of about 57 months, according to a study presented at the American Society of Clinical Oncology annual Genitourinary Cancers Symposium, held from Jan. 25 to 27 in San Francisco.Ton

HealthDay 11 January at 06.16 PM

End-of-Life Treatment With Immunotherapy Increasing for Patients With Cancer

Initiation of immunotherapy for metastatic cancer at the end of life (EOL) is increasing over time, according to a study published online Jan. 4 in JAMA Oncology.Daniel M. Kerekes, M.D., from Yale University in New Haven, Connecticut, and colleagues examined patient characteristics, practice patterns, and risk factors concerning